Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers.

by Sergio Barroso, Constanza Morén, Àlex González-Segura, Neus Riba, Joan A Arnaiz, Marcela Manriquez, Gemina Santana, José L Blanco, María Larousse, Montse Loncà, Elisa de Lazzari, Jaume Llopis, Josep Mallolas, Oscar Miró, Xavier Carné, Jose M Gatell, Glòria Garrabou, Esteban Martínez
Published 2019-01-01